Replay available

PROCEPT BioRobotics Corporation (PRCT) Q2 2025 Earnings Call

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Q2 2025 earnings conference call, held 2025-08-06. Replay captured from the company's public earnings webcast.

Wed, August 6, 2025 at 4:30 PMendedReplay
PROCEPT BioRobotics Corporation (PRCT) Q2 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Matthew O'Brien

Analyst, Piper Sandler

Larry Wood

Incoming Chief Executive Officer

Ryan Zimmerman

Analyst, BTIG

Kevin Waters

Chief Financial Officer

Richard Newitter

Analyst, Truist Securities

Mason Currico

Analyst, Stephens

Matt Baxo

Vice President, Investor Relations

Chris Pesquale

Analyst, Nefron Research

Reza Zadno

Chief Executive Officer

Patrick Wood

Analyst, Morgan Stanley

Siraj Khalia

Analyst, Oppenheimer & Co.

Eric Onfroyer

Analyst, TD Cowen

Brandon Fesquette

Analyst, William Blair

Michael Cercone

Analyst, Jefferies

Nathan Trebek

Analyst, Wells Fargo

Replay transcript excerpt

listen-only mode. We will be facilitating a question and answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Matt Baxo, Vice President of Vassar Relations, for a few introductory comments. Good afternoon, and thank you for joining ProCEP Biorebotics' second quarter 2025 earnings conference call. Presenting on today's call are Reza Zadno, Chief Executive Officer, Larry Wood, incoming Chief Executive Officer, and Kevin Waters, Chief Financial Officer. Before we begin, I'd like to remind listeners that statements made on this conference call that relate to future plans, events, or performance are forward-looking statements as defined under the Private Securities, Litigation, and Reform Act of 1995. While these forward-looking statements are based on management's current expectations and beliefs, these statements are subject to several risks, uncertainties, assumptions, and other factors that could cause results to differ materially from the expectations expressed on this conference call. These risks and uncertainties are disclosed in more detail in ProCEP Biorebotics' filings with the Securities and Exchange Commission, all of which are available online at .sec.gov. Listeners are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date, August 6, 2025. Accepted as required by law, ProCEP Biorebotics undertakes no obligation to update or revise any forward-looking statements to reflect new information, circumstances, or unanticipated events that may arise. During the call, we will also reference certain financial measures that are not prepared in accordance with GAAP. More information about how we use these non-GAAP f...

More from Procept Biorobotics Corporation